Clinical Trials Logo

Filter by:
NCT ID: NCT04858932 Completed - Healthy Clinical Trials

Geriatric Anorexia Study

GAS
Start date: April 27, 2021
Phase:
Study type: Observational

Reduction in appetite and/or food intake among older individuals is referred to as anorexia of aging (AOA, also known as Geriatric Anorexia). AOA is linked with myriad comorbidities associated with aging, contributes significantly to adverse health consequences in old age, and has been used as a predictor of morbidity and mortality. The overall aim of this study is to assess the feasibility and burden of the proposed in-laboratory and out-of-laboratory assessments to study Geriatric Anorexia. This will be accomplished with the use of questionnaires as well as devices that evaluate movement, metabolism, body weight composition, glucose levels, and nutritional scale.

NCT ID: NCT04858815 Completed - Stress Clinical Trials

Using Yogic Breathing to Reduce Stress in Anesthesia Personnel as Measured by Hair Cortisol

Start date: April 26, 2021
Phase: N/A
Study type: Interventional

Mind body exercises have long been used as a way for individuals to reduce stress and improve well-being. Recent studies indicate that yogic breathing (YB, also known as pranayama) could potentially impact both the mind and body by engaging both the physiological and neural elements and can thus be a specific tool that can be utilized by healthcare workers to combat burnout and decrease perceived levels of stress. Our aim is to understand and measure both subjectively and objectively the effects of long-term yogic breathing on stress levels in anesthesia personnel. This will be a single arm longitudinal trial designed to evaluate the feasibility and estimate the efficacy of implementing a yogic breathing program for stress reduction among anesthesiology practitioners at one academic medical center. The primary aim of the trial is to estimate the correlation between participant stress with average duration of yogic breathing over time. Secondarily the feasibility of implementing yogic breathing practices among anesthesiology practitioners will be evaluated. Feasibility measures will include recruitment rates, retention at 1year follow-up, and adherence to the yogic breathing program at 12 months.

NCT ID: NCT04858802 Completed - Clinical trials for Chronic Rhinosinusitis (Diagnosis)

A Clinical Evaluation of PROPEL® Contour Sinus Implant

EXPAND
Start date: May 12, 2021
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the efficacy of PROPEL Contour placement following an in-office frontal sinus balloon dilation (SBD) in patients with chronic rhinosinusitis (CRS)

NCT ID: NCT04858542 Completed - Health Behavior Clinical Trials

Evaluating the Impact of Vocal Health Education on Mask-wearing Workers During COVID-19

Start date: February 26, 2021
Phase: N/A
Study type: Interventional

The purpose of this clinical trial is to understand how viewing educational health modules impacts vocal health behaviors in mask-wearing healthcare workers.

NCT ID: NCT04858295 Completed - Hypertension Clinical Trials

Supporting Self-Management of Healthy Behaviors in Chronic Kidney Disease

SMART-HABITS
Start date: July 26, 2021
Phase: N/A
Study type: Interventional

The pilot cross-over study aims to examine the feasibility of a smartphone-based self-management supportive intervention, Supporting Self-Management of Healthy Behaviors (SMART-HABITS) in patients with chronic kidney disease (CKD) and hypertension. SMART-HABITS is a web-based application accessible on any device that has Internet access and utilizes a mobile health research platform (Way to Health) that links to wearable sensor smartphone applications such as FitBit and Omron Connect, to provide reminders, tailored feedback, and provide access to educational resources, and to community resources. The cross-over design is used to test preferences of using text message or a smartphone app to communicate blood pressure readings.

NCT ID: NCT04858178 Completed - Clinical trials for Spinal Cord Injuries

Transcutaneous Spinal Cord Neuromodulation to Normalize Autonomic Phenotypes

Start date: February 17, 2022
Phase: N/A
Study type: Interventional

This study looks to characterize autonomic nervous system dysfunction after spinal cord injury and identify the potential role that transcutaneous spinal cord stimulation may play at altering neuroregulation. The autonomic nervous system plays key parts in regulation of blood pressure, skin blood flow, and bladder health- all issues that individuals with spinal cord injury typically encounter complications. For both individuals with spinal cord injury and uninjured controls, experiments will utilize multiple parallel recordings to identify how the autonomic nervous system is able to inhibit and activate sympathetic signals. The investigators anticipate that those with autonomic dysfunction after spinal cord injury will exhibit abnormalities in these precise metrics. In both study populations, transcutaneous spinal cord stimulation will be added, testing previously advocated parameters to alter autonomic neuroregulation. In accomplishing this, the investigators hope to give important insights to how the autonomic nervous system works after spinal cord injury and if it's function can be improved utilizing neuromodulation.

NCT ID: NCT04858126 Completed - Clinical trials for Hemodynamic Monitoring

Accuracy of ECOM Plus Versus Pulmonary Artery Catheter

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

This Study will compare the accuracy of the ECOM Plus Endotracheal Cardiac Output Monitor (ECOM) without the use of the arterial pressure waveform from the arterial line to 1) the current clinical standard of cardiac output measured by intermittent room temperature bolus thermodilution using a PAC, 2) the current ECOM System with the use of the arterial blood pressure waveform from a radial arterial line and 3) the Flo-Trac® System.

NCT ID: NCT04857996 Completed - Clinical trials for Diabetic Macular Edema (DME)

Safety, Tolerability and Evidence of Activity Study of UBX1325 in Patients With Diabetic Macular Edema (BEHOLD)

Start date: June 25, 2021
Phase: Phase 2
Study type: Interventional

This study is intended to assess the exposure, safety, biological activity, and durability of UBX1325, a phosphate pro-drug, and its active parent molecule (UBX0601) following a single intravitreal (IVT) injection of UBX1325 in patients with diabetic macular edema (DME).

NCT ID: NCT04857957 Completed - Clinical trials for Painful Diabetic Neuropathy

Safety, Tolerability & Pharmacokinetics Study of CNTX-6016 in Healthy Subjects and Subjects With PDN

Start date: April 14, 2021
Phase: Phase 1
Study type: Interventional

A Phase 1b study to evaluate the safety, tolerability and pharmacokinetics of multiple ascending doses of CNTX-6016 in healthy subjects and a single cohort to evaluate painful diabetic neuropathy.

NCT ID: NCT04857892 Completed - HIV Infections Clinical Trials

A Relative Bioavailability and Food-Effect Study of the Fixed Dose Combination of GSK3640254 and Dolutegravir (DTG) in Healthy Participants

Start date: April 21, 2021
Phase: Phase 1
Study type: Interventional

This is a two part study to compare the relative bioavailability (BA) of 2 fixed dose combinations (FDCs) of GSK3640254/DTG with GSK3640254 and DTG administered together as single agents (Part 1) and to assess the effect of food on the pharmacokinetic (PK) of the selected FDC of GSK3640254/DTG (Part 2).